Dipòsit Digital de Documents de la UAB
Publication
Artículo científico (JournalArticle)
Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders
Obesity and type 2 diabetes are associated with cognitive dysfunction. Because the hypothalamus is implicated in energy balance control and memory disorders, we hypothesized that specific neurons in this brain region are at the interface of metabolism and cognition. Acute obesogenic diet administration in mice impaired recognition memory due to defective production of the neurosteroid precursor pregnenolone in the hypothalamus. Genetic interference with pregnenolone synthesis by Star deletion in hypothalamic POMC, but not AgRP neurons, deteriorated recognition memory independently of metabolic disturbances. Our data suggest that pregnenolone's effects on cognitive function were mediated via an autocrine mechanism on POMC neurons, influencing hippocampal long-term potentiation. The relevance of central pregnenolone on cognition was also confirmed in metabolically unhealthy patients with obesity. Our data reveal an unsuspected role for POMC neuron-derived neurosteroids in cognition. These results provide the basis for a framework to investigate new facets of POMC neuron biology with implications for cognitive disorders. Ramírez et al. show that reduced hypothalamic pregnenolone levels, in the context of metabolic diseases, are associated with cognitive deterioration. POMC neuron-derived pregnenolone is a key mediator of cognition, but not metabolism, acting via hippocampal mechanisms. These results identify an unsuspected role for POMC neuron-derived pregnenolone in memory performance.
Project:
Fundació la Marató de TV3 20141210
,
Fundació la Marató de TV3 201614.31
,
Fundació la Marató de TV3 201916/31
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-737
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1112
,
Agència de Gestió d'Ajuts Universitaris i de Recerca SLT006/17/00119
,
Agència de Gestió d'Ajuts Universitaris i de Recerca SLT006/17/125
,
Agència de Gestió d'Ajuts Universitaris i de Recerca SLT008/18/00127
,
Agencia Estatal de Investigación PID2019-111669RB-I00
,
Agencia Estatal de Investigación PID2020-115055RB-I00
,
European Commission 725004
,
European Commission 891247
,
Instituto de Salud Carlos III PI17/00296
,
Ministerio de Economía y Competitividad PI14/01126
,
Instituto de Salud Carlos III PI17/01019
,
Instituto de Salud Carlos III PI17/00279
,
Instituto de Salud Carlos III PI20/0042
,
Ministerio de Economía y Competitividad PI16/00963
,
Instituto de Salud Carlos III INT19/00016
,
Instituto de Salud Carlos III CP19/00083
,
Agencia Estatal de Investigación BFU2017-83317-P
,
Ministerio de Ciencia e Innovación FJCI-2016-28911
,
Ministerio de Ciencia e Innovación IJC2018-037341-I
,
Ministerio de Economía MDM-2017-0729